Literature DB >> 12381938

Involvement of interleukin-18 in patients on maintenance haemodialysis.

S Gangemi1, A Mallamace, P L Minciullo, D Santoro, R A Merendino, V Savica, G Bellinghieri.   

Abstract

Maintenance dialysis induces a clinical state of immunodeficiency. The pathway of circulating T cells from haemodialyzed patients is changed and characterized by an increase of Th1 cells. The unbalanced T helper differentiation derives from an altered regulation of interleukin-12 (IL-12), which represents an important inducer of Th1. IL-18 is a pro-inflammatory cytokine expressed by a variety of cell types that is structurally related to the Th1 family and shares biological properties with IL-12 as the promotion of Th1 responses. To explain the involvement of IL-18 in the typical disorders of dialysis, we analyzed IL-18 serum levels in a group of haemodialyzed patients. We enrolled 16 patients on chronic haemodialysis (HD) treatment for end-stage renal failure and 16 healthy volunteers as the control group. IL-18 levels were assessed by immunoenzymatic methods (detection limit was <12.5 pg/ml). HD patients strongly showed higher IL-18 serum levels compared to healthy donors (508.47 +/- 314.39 vs. 193.44 +/- 56.33 pg/ml, p < 0.005). Moreover, IL-18 levels in HD directly correlated to dialytic age (Rho = 0.544, p = 0.0419) and indirectly to Kt/V (Rho = 0.703, p = 0.0086). Our data represent the first evidence of the relation between IL-18 serum levels and HD. In the light of our results, we think that the unbalanced T helper differentiation may depend, at least in part, on an abnormality in the IL-18 production. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12381938     DOI: 10.1159/000065269

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  7 in total

1.  Plasma inflammatory and apoptosis markers are associated with dialysis dependence and death among critically ill patients receiving renal replacement therapy.

Authors:  Raghavan Murugan; Xiaoyan Wen; Nilesh Shah; Minjae Lee; Lan Kong; Francis Pike; Christopher Keener; Mark Unruh; Kevin Finkel; Anitha Vijayan; Paul M Palevsky; Emil Paganini; Melinda Carter; Michele Elder; John A Kellum
Journal:  Nephrol Dial Transplant       Date:  2014-03-11       Impact factor: 5.992

Review 2.  Inflammasomes in the Pathophysiology of Kidney Diseases.

Authors:  Humaira Masood; Ruochen Che; Aihua Zhang
Journal:  Kidney Dis (Basel)       Date:  2015-09-04

3.  SOD3 and IL-18 Predict the First Kidney Disease-Related Hospitalization or Death during the One-Year Follow-Up Period in Patients with End-Stage Renal Disease.

Authors:  Yu-Hsien Liu; Yu-Hsuan Chen; Chi-Hua Ko; Chia-Wen Kuo; Chih-Ching Yen; Wei Chen; Kowit-Yu Chong; Chuan-Mu Chen
Journal:  Antioxidants (Basel)       Date:  2022-06-18

4.  Serum IL-18 is closely associated with renal tubulointerstitial injury and predicts renal prognosis in IgA nephropathy.

Authors:  Beili Shi; Zhaohui Ni; Liou Cao; Minjie Zhou; Shan Mou; Qin Wang; Minfang Zhang; Wei Fang; Yucheng Yan; Jiaqi Qian
Journal:  Mediators Inflamm       Date:  2012-02-06       Impact factor: 4.711

5.  Is the inflammasome a potential therapeutic target in renal disease?

Authors:  Clare M Turner; Nishkantha Arulkumaran; Mervyn Singer; Robert J Unwin; Frederick W K Tam
Journal:  BMC Nephrol       Date:  2014-01-23       Impact factor: 2.388

6.  Renoprotective Effect of KLF2 on Glomerular Endothelial Dysfunction in Hypertensive Nephropathy.

Authors:  Eunjin Bae; Mi-Yeon Yu; Jong-Joo Moon; Ji-Eun Kim; Saram Lee; Sang-Woong Han; Dong-Jun Park; Yon-Su Kim; Seung-Hee Yang
Journal:  Cells       Date:  2022-02-22       Impact factor: 6.600

7.  SGK1-dependent stimulation of vascular smooth muscle cell osteo-/chondrogenic transdifferentiation by interleukin-18.

Authors:  Nadeshda Schelski; Trang T D Luong; Florian Lang; Burkert Pieske; Jakob Voelkl; Ioana Alesutan
Journal:  Pflugers Arch       Date:  2019-01-31       Impact factor: 3.657

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.